Meeting
2021 Genitourinary Cancers Symposium
Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study.
Authors
Daniel Kwon
UCSF, San Francisco, CA
Daniel Kwon , Rohit Vashisht , Hala Borno , Rahul Raj Aggarwal , Eric Jay Small , Atul Butte , Franklin W. Huang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Impact of COVID-19
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 37)
DOI
10.1200/JCO.2021.39.6_suppl.37
Abstract #
37
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer.
First Author: Vaibhav G. Patel
Poster
2021 Genitourinary Cancers Symposium
Severe-COVID-19 and mortality among patients (pts) with prostate cancer (PCa) receiving androgen deprivation therapy (ADT).
First Author: Matthew D Tucker
Poster
2023 ASCO Annual Meeting
Assessing racial differences in time to treatment escalation following androgen-deprivation therapy among veterans with prostate cancer.
First Author: Nadine Adriana Friedrich
Poster
2024 ASCO Breakthrough
Racial impact of secondary metastasis in patients with lung cancer: Evidence of US hospitals in 2020.
First Author: Thanathip Suenghataiphorn